SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Solid Biosciences Inc. SLDB NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Solid Biosciences Inc. (SLDB) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRV, ALEC, ANEB, BCEL, BDTX, CABA and others.

SLDB has a market capitalization of $648.21M, compared to an average peer market cap of $619.76M.

Peers & Similar Companies — SLDB

Acrivon Therapeutics, Inc. Common Stock

$1.67 +1.83% $52.7M

$2.58 +7.05% $284.74M

Anebulo Pharmaceuticals, Inc.

$0.50 0.00% $20.39M

$0.09 -1.32% $3.57M

Black Diamond Therapeutics, Inc.

$2.87 +7.89% $164.42M

Cabaletta Bio, Inc.

$3.40 +4.29% $327.3M

C4 Therapeutics, Inc.

$2.89 +4.90% $239.37M

Cullinan Oncology, Inc.

$14.95 +4.18% $904.87M

Edgewise Therapeutics, Inc.

$33.70 +1.63% $3.62B

Monte Rosa Therapeutics, Inc.

$18.23 +4.17% $1.19B

Century Therapeutics, Inc.

$2.59 +9.28% $224.21M

Larimar Therapeutics, Inc.

$4.83 -0.82% $413.34M

People Also View

Revolution Medicines, Inc.

Edgewise Therapeutics, Inc.

Stoke Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

Cullinan Oncology, Inc.

Larimar Therapeutics, Inc.

Cabaletta Bio, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message